缬沙坦对原发性高血压患者血清尿酸水平的影响
被引量:1
摘要
缬沙坦是一种血管紧张素受体拮抗剂,其抗高血压疗效已获充分肯定.但目前关于缬沙坦与其他血管紧张素受体拮抗剂对血尿酸影响的对比研究报道较少.本研究旨在观察血管紧张素Ⅱ受体拈抗剂(ARB)缬沙坦对原发性高血压患者血清尿酸水平的影响。
出处
《浙江医学》
CAS
2010年第9期1409-1411,共3页
Zhejiang Medical Journal
参考文献12
-
1Liese AD,Hense HW,Lowel H,et al.Association of serum uric acid with allcause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort[J].Epidemiology,1999,10(4):391.
-
2Wen-Harn Pan,Tseng CH.Independent association of uric acid levels with peripheral arterial disease in Taiwan Residents patients with type 2 diabetes[J].Diabet Meal,2004,21(7):724.
-
3Nieto,Bogdanovska S,Lozance LJ.Serum levels of uric acid lipids and glucose in essential hypertension[J].Srip Arh Celok L ck,1996,124(Supp ll):214-216.
-
4Culleton BF,Larson MG,Kannel WB,et al.Serum uric acid and risk for cardiovascular disease and death:the Framingham heart study[J].Ann Intern Med,1999,131(1):7-13.
-
5Sundstrom J,Sullivan LD,Agostino RB,et al.Relation of serum uric acid to longitudial blood pressure tracking and hypertension incidence[J].Hypertension,2005,45(1):28-33.
-
6符彬,陈新.高尿酸血症与心血管疾病关系的Meta分析[J].中国全科医学,2007,10(6):451-453. 被引量:50
-
7丁国宪,刘超.老年高尿酸血症与心血管疾病[J].实用老年医学,2006,20(1):3-5. 被引量:13
-
8Sica DA,Schoolwerth AC.Part 1,uric acid and losartan[J].Curr Opin Nephrol Hypertens,2002,11(5):475-482.
-
9杨莉,金醒昉,高辉.缬沙坦治疗老年高血压并发高尿酸血症的临床观察[J].中国老年学杂志,2001,21(3):192-193. 被引量:15
-
10马洪山,刘艳春,张晓明.缬沙坦治疗高血压病患者伴血尿酸增高40例临床观察[J].中国药物与临床,2003,3(3):265-266. 被引量:8
二级参考文献39
-
1李婧,李莉,陈文强,葛云玲,周其华,宗春饶.尿酸与冠心病病变程度的相关性[J].中国误诊学杂志,2004,4(11):1851-1851. 被引量:7
-
2门可,李良寿.循证医学(三)——Meta分析[J].疑难病杂志,2005,4(1):58-61. 被引量:18
-
3富振英.Meta-Analysis研究资料的统计分析方法(一)[J].药物流行病学杂志,1994,3(4):220-222. 被引量:67
-
4梁万年,王存亮.Meta分析的质量评价[J].中国全科医学,2005,8(18):1502-1503. 被引量:5
-
5洪明晃.Meta-analysis简介[J].中国卫生统计,1992,1:57-59.
-
6Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men [ J ]. JAMA,2002,288 (21):2709.
-
7Faro AG. Gout , diet, and the insulin resistance syndrome [ J ]. Jrheumatol,2002,29(7) : 1550.
-
8Desselin PH, Shipton EA, Stanwix AE,et al. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction ,and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study[J]. Ann Rheum Dis,2000,59 (7) :539.
-
9Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES Ⅰ epidemiologic follow up study. 1971-1992 [ J ]. JAMA, 2000,283 ( 8 ):2404.
-
10Culleton BF, Larson MG, Kannel WB,et al. Serum uric acid and risk of cardiovascular disease and death:the Framingham Heart Study [J].Ann Intern Med,1999,131 (1):7.
共引文献81
-
1汤瑜昳,杨德辉,易定锋.阿利沙坦酯和缬沙坦治疗高血压病合并高尿酸血症效果比较[J].湖南师范大学学报(医学版),2020,17(1):40-42. 被引量:20
-
2陈秋琴,吴慧英,翁春梅,刘广军.缬沙坦的临床应用进展[J].中国基层医药,2005,12(5):627-628. 被引量:8
-
3戴秋艳,孙宝贵,吴莹,汪玮,徐梦丹,刘海.厄贝沙坦-氢氯噻嗪片对原发性高血压患者血尿酸的影响[J].中国临床药学杂志,2005,14(5):271-273. 被引量:2
-
4樊广渊,许晓明.氯沙坦与苯那普利降压及降尿酸作用对比观察[J].陕西医学杂志,2006,35(5):598-599. 被引量:2
-
5陈康,符晓腾.高尿酸血症与高血压病关系探讨[J].中国社区医师(医学专业),2006,8(21):29-29. 被引量:1
-
6郭义恒,于改革.缬沙坦联合氟伐他汀治疗慢性尿酸性肾病临床观察[J].实用诊断与治疗杂志,2006,20(12):892-893. 被引量:1
-
7戈霓云.缬沙坦和拜新同治疗高血压的临床观察[J].中国药业,2007,16(5):59-60. 被引量:2
-
8李红羽,JIN Cheng-Lie.降尿酸汤治疗老年原发性高尿酸血症的临床研究[J].中国老年学杂志,2007,27(13):1282-1284. 被引量:5
-
9赵源浩,李妍,牟燕.影响血清尿酸浓度的药物[J].中国药师,2007,10(7):697-699. 被引量:2
-
10胡守岳,陈贞羽.1679例高尿酸血症危险因素分析[J].浙江实用医学,2007,12(5):324-325. 被引量:6
同被引文献17
-
1李艳萍.氯沙坦、缬沙坦联合氨氯地平治疗原发性高血压并高尿酸血症的对比研究[J].南华大学学报(医学版),2007,35(3):404-406. 被引量:17
-
2Hoieggen A,Os I,Kjeldsen SE.Uric acid-more deleterious than we thought[J].Tidsskr Nor Laegeforen,2005,125(10):1330-1332.
-
3Miao Y,Ottenbros SA,Laverman GD,et al.Effect of a reduction in uric acid on renal outcomes during losartan treatment:a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial[J].Hypertension,2011,58(1):2-7.
-
4Liu T,Zhang X,Korantzopoulos P,et al.Uric Acid Levels and Atrial Fibrillation in Hypertensive Patients[J].Intern Med,2011,50(8):799-803.
-
5Wllk BP,Larstorp AC,Hieggen A,et al.Serum uric acid is associatedwith new-onset diabetes in hypertensive patients with left ventricular hy-pertrophy:The LIFE Study[J].Am J Hypertens,2010,23(8):845-851.
-
6Nakamura M,Anzai N,Jutabha P,et al.Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters[J].J Pharmacol Sci,2010,114(1):115-118.
-
7Sundstrm J,Sullivan L,D'Agostino RB,et al.Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence[J].Hypertension,2005,45(1):28-33.
-
8Uetake D,Ohno I,Ichida K,et al.Effect of Fenofibrate on Uric Acid Metabolism and Urate Transporter 1[J].Intern Med,2010,49(9):89-94.
-
9Seifi B,Kadkhodaee M,Zahmatkesh M.Effect of vitamin E therapy on serum uric acid in DOCA-salt-treated rats[J].Acta Physiol Hung,2011,98(2):214-220.
-
10Brymora A,Flisinski M,Johnson RJ,et al.Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease[J].Nephrol Dial Transplant,2011,49(9):54.
二级引证文献4
-
1胡庆伟.单纯降压和降尿酸治疗高尿酸血症合并原发性高血压疗效分析[J].局解手术学杂志,2013,22(3):297-298. 被引量:2
-
2李小燕,郭世俊,李春霖.原发性高血压合并高尿酸血症患者的中医体质特点[J].广东医学,2015,36(6):955-957. 被引量:20
-
3李愔,秦福芳,易华.氯沙坦联合氢氯噻嗪对高血压合并高尿酸血症患者血压和血尿酸的影响[J].中国农村卫生,2016,8(04X):12-12. 被引量:1
-
4陈代国.高尿酸血症合并高血压的药物选择探讨[J].中国现代医生,2014,52(35):154-156. 被引量:4
-
1崔兆强,陈曦,常文静,陈兰英,黄楚滨,胡爱华,刘力生.血管紧张素Ⅱ受体对心肌重塑的相关性研究[J].中华心血管病杂志,1999,27(4):307-310. 被引量:56
-
2万发银,汪家瑞.血管紧张素Ⅱ受体与心肌肥厚的关系[J].心功能杂志,1999,11(3):185-187. 被引量:3
-
3袁志敏.血管紧张素Ⅱ受体拮抗剂与高血压[J].国外医学(老年医学分册),2000,21(4):171-173. 被引量:7
-
4庞明.血管紧张素II受体与高血压[J].医学文选,2000,19(3):379-381. 被引量:1
-
5周永宏.缬沙坦治疗高血压对心房颤动发生率的影响[J].临床医药实践,2009,18(3):193-195. 被引量:1
-
6胡大一,赵秀丽.血管紧张素Ⅱ受体拮抗剂治疗高血压的研究进展[J].现代康复,1999,3(10):1204-1206. 被引量:6
-
7许英萍.缬沙坦的临床应用研究进展[J].杭州师范学院学报(医学版),2008,28(5):355-357. 被引量:5
-
8张立荣.替米沙坦与硝苯地平联合用药在高血压治疗中的应用[J].中国保健营养(下半月),2012,0(7):2784-2784.
-
9彭鹰,苏珂.血管紧张素Ⅱ受体拮抗剂治疗糖尿病的研究进展[J].华夏医学,2001,14(6):988-990.
-
10张茜.血管紧张素Ⅱ受体与血管平滑肌细胞的增生、肥大[J].高血压杂志,1997,5(1):64-67. 被引量:11